Front. Immunol. Frontiers in Immunology Front. Immunol. 1664-3224 Frontiers Media S.A. 10.3389/fimmu.2024.1494595 Immunology Erratum Erratum: Plasma protein profiling reveals dynamic immunomodulatory changes in multiple sclerosis patients during pregnancy Frontiers Production Office * Frontiers Media SA, Lausanne, Switzerland

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

*Correspondence: Frontiers Production Office, production.office@frontiersin.org

20 09 2024 2024 15 1494595 11 09 2024 11 09 2024 Copyright © 2024 Frontiers Production Office 2024 Frontiers Production Office

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 An Erratum on Plasma protein profiling reveals dynamic immunomodulatory changes in multiple sclerosis patients during pregnancy By Papapavlou Lingehed G, Hellberg S, Huang J, Khademi M, Kockum I, Carlsson H, Tjernberg I, Svenvik M, Lind J, Blomberg M, Vrethem M, Mellergård J, Gustafsson M, Jenmalm MC, Olsson T and Ernerudh J (2022) Front. Immunol. 13:930947. doi: 10.3389/fimmu.2022.930947 multiple sclerosis pregnancy Olink proteomics plasma inflammation cytokines hormones section-in-acceptance Immunological Tolerance and Regulation

Due to a production error, the line “113/33 proteins, odds ratio (OR): 98.9, p=4.85e-09, Fisher’s exact test, Figure 4B” was incorrectly inserted.

A correction has been made to the section “Results”, sub-section “Differentially expressed proteins during pregnancy in MS”, paragraph three. The corrected text appears below:

“13/33 proteins, odds ratio (OR): 98.9, p=4.85e-09, Fisher’s exact test, Figure 4B)”

Due to the same error, the line “remains to be determined” was also incorrectly omitted.

A correction has been made to the section “Discussion”, paragraph two. The corrected text appears below:

“However, whether the circulating levels of IL-10RB and CSF-1 are associated with beneficial effects on CNS inflammation remains to be determined.”

The publisher apologizes for these mistakes.

The original version of this article has been updated.